African Swine Fever

African swine fever is a highly contagious and devastating viral disease of domestic pigs and wild boar caused by African swine fever virus, a large DNA virus that is the sole member of the family Asfarviridae. This disease produces severe hemorrhagic fever with mortality rates approaching one hundred percent in naive pig populations exposed to virulent strains. African swine fever represents one of the most significant threats to global swine production and food security, with ongoing pandemic spread causing unprecedented losses in pig populations across multiple continents. The disease has no approved vaccine or treatment, making prevention through stringent biosecurity the only effective control measure.

African swine fever affects all breeds of domestic pigs regardless of age, sex, or production stage, with wild boar and feral pigs equally susceptible to infection. The disease is endemic in sub-Saharan Africa where it circulates among warthogs and soft tick vectors, and has established presence in parts of Europe, Asia, and Oceania following pandemic spread that began in 2007. Certain regions maintain disease-free status through rigorous surveillance and biosecurity, though the threat of introduction remains constant. The 2018 introduction to China resulted in the deaths and culling of hundreds of millions of pigs, demonstrating the catastrophic impact potential when the virus enters major pig-producing regions.

The economic impact of African swine fever extends far beyond direct mortality to encompass trade restrictions, market disruptions, and food security implications affecting entire national economies. Countries experiencing outbreaks face immediate closure of export markets for pork products, devastating industries built on international trade. Consumer prices increase as supply contracts while producer income collapses. Food security concerns emerge in regions dependent on pork as a primary protein source. The costs of surveillance, response, and recovery from outbreaks strain government and industry resources. Endemic presence in wild boar populations creates ongoing challenges for eradication and maintenance of disease-free status.

African swine fever is a reportable disease in all countries, requiring immediate notification of animal health authorities upon suspicion or confirmation. There is no effective treatment for infected pigs, and no approved vaccine is commercially available despite intensive global research efforts. Control relies entirely on rapid detection, strict quarantine, depopulation of infected and exposed animals, and rigorous biosecurity to prevent viral spread. Understanding the transmission routes, clinical presentation, and regulatory requirements for African swine fever is essential for all stakeholders in the swine industry to protect animal health and enable rapid response should this disease threaten their operations.

African swine fever is caused by African swine fever virus, a large, complex, double-stranded DNA virus that is the only member of the family Asfarviridae and genus Asfivirus. The virus particle measures approximately two hundred nanometers in diameter and possesses a complex structure including an outer membrane that facilitates entry into host cells. Multiple genotypes of the virus exist with varying geographic distributions and virulence characteristics, though all cause serious disease in susceptible pigs. The virus demonstrates remarkable genetic stability compared to many other viruses, maintaining virulence characteristics even after extended circulation in new host populations.

Genetic and breed predisposition to African swine fever is essentially absent, with all domestic pig breeds demonstrating equivalent susceptibility to infection and disease. European and Asian domestic pig breeds that have never experienced evolutionary exposure to the virus lack any resistance mechanisms. Interestingly, African wild suids including warthogs and bushpigs serve as natural reservoir hosts, carrying the virus without clinical disease due to long evolutionary coexistence. This species-specific resistance does not extend to domestic pigs regardless of their genetic background. No practical genetic selection for resistance is feasible given the severity of disease and regulatory requirements for immediate response.

Environmental factors significantly influence African swine fever virus transmission and survival outside living hosts. The virus demonstrates exceptional environmental stability, remaining infectious for months in refrigerated meat products and potentially years in frozen materials. It survives for extended periods in cured meat products including ham and sausages that have not undergone adequate heat treatment. Contaminated premises may harbor infectious virus for weeks in organic material and blood residues. The virus resists many common disinfectants, though hypochlorite solutions, strong detergents, and some commercial products provide effective inactivation when properly applied. Temperature extremes and sunlight exposure accelerate environmental inactivation.

Transmission of African swine fever occurs through multiple routes that must all be addressed in prevention programs. Direct contact between infected and susceptible pigs represents the most efficient transmission pathway, with virus shed in all secretions and excretions including blood, saliva, urine, feces, and semen. Indirect transmission through contaminated fomites including vehicles, equipment, clothing, and feed poses serious risks given the virus's environmental stability. Swill feeding using inadequately processed food waste containing infected pork products has historically caused numerous outbreaks. Soft ticks of the genus Ornithodoros serve as biological vectors in endemic African areas and parts of Europe, maintaining virus through transstadial and transovarial transmission.

The pathophysiology of African swine fever involves viral infection and destruction of cells throughout the mononuclear phagocyte system along with vascular endothelial damage causing hemorrhagic manifestations. Following exposure, the virus initially replicates in regional lymph nodes before entering the bloodstream and disseminating to all organs. Primary target cells include monocytes and macrophages, whose destruction releases inflammatory mediators contributing to fever and systemic illness. Infection of vascular endothelial cells causes increased permeability and hemorrhage affecting multiple organs. The resulting coagulopathy produces the characteristic hemorrhagic lesions seen at necropsy. Immunosuppression from macrophage destruction leaves infected animals vulnerable to secondary infections that may complicate the clinical picture.

Early warning signs of African swine fever in pig populations may initially appear nonspecific, resembling various common diseases before the characteristic hemorrhagic syndrome develops. Initial signs often include high fever exceeding 104 degrees Fahrenheit, decreased feed consumption, and general depression with reduced activity. Pigs may huddle together despite warm environmental temperatures. Pregnant sows may abort without other obvious signs. Some producers report increased water consumption in early stages. These subtle early signs may be overlooked in large commercial operations before disease progression makes the outbreak obvious.

Classic symptoms of acute African swine fever include severe clinical manifestations affecting multiple body systems. High fever reaching 105 to 107 degrees Fahrenheit develops early and persists throughout the disease course. Affected pigs show profound weakness with reluctance to stand or move. Vomiting and diarrhea may occur, with diarrhea sometimes containing blood. Respiratory distress develops with increased breathing rate and effort. Nasal discharge may be blood-tinged. Reddening of the skin progresses to purple discoloration of the ears, tail, lower legs, and ventral abdomen as hemorrhage develops. Conjunctivitis with reddened eyes and ocular discharge is common.

Behavioral changes accompanying African swine fever reflect the severe systemic illness produced by this virus. Affected pigs become markedly depressed with complete loss of appetite and interest in surroundings. Pigs seek isolation from penmates and may be found lying in corners or against walls. Normal social behaviors cease as sick animals lack energy for interaction. Affected pigs resist handling and may vocalize when moved due to pain from internal hemorrhage. Some animals show neurological signs including tremors, incoordination, and convulsions before death. The rapidity of decline from apparently normal to severely ill is notable and alarming to observers.

Physical signs of African swine fever become increasingly dramatic as disease progresses. Skin discoloration begins as reddening that progresses through purple to black coloration, particularly affecting the ears, snout, legs, and ventral body areas. Hemorrhages may be visible through the skin or cause swelling when blood accumulates in tissues. Edema of the eyelids and face creates a swollen appearance. Bloody discharge from the nose and mouth may occur. Rectal temperatures remain elevated throughout, distinguishing African swine fever from some look-alike conditions where fever may decline terminally. Body condition deteriorates rapidly due to anorexia and catabolic state.

Symptom progression in acute African swine fever follows a rapid and typically fatal course. Following an incubation period of four to nineteen days depending on exposure route and viral strain, fever and depression develop abruptly. Clinical deterioration over subsequent days produces the full hemorrhagic syndrome. Death typically occurs within seven to fourteen days of symptom onset in acute disease caused by virulent strains, with mortality approaching one hundred percent in naive populations. Some strains produce subacute or chronic disease with extended clinical courses and lower mortality, though these presentations are less common with currently circulating virulent genotypes.

Emergency symptoms requiring immediate investigation and reporting include any combination of high fever, skin reddening or hemorrhage, and unexplained mortality affecting multiple pigs. Sudden deaths without premonitory signs demand immediate attention. Any disease picture resembling classical swine fever or other hemorrhagic conditions requires urgent differentiation. Abortion storms in sow herds warrant investigation. Because African swine fever is a reportable disease, suspicion of infection requires immediate notification of veterinary authorities who will direct subsequent diagnostic investigation and response activities.

Clinical examination of pigs suspected of having African swine fever must be conducted with full awareness of the biosecurity implications of a positive finding. Physical examination reveals the characteristic hemorrhagic syndrome with high fever, skin discoloration, and multi-organ involvement. Careful documentation of clinical signs, affected animals, and timeline of disease progression supports epidemiological investigation. Any suspicion of African swine fever requires immediate notification of official veterinary authorities who will direct diagnostic sampling and testing through approved laboratories. Clinical examination alone cannot confirm diagnosis, which requires laboratory testing given the similarity to other hemorrhagic conditions.

Diagnostic testing for African swine fever employs multiple laboratory methods to detect virus, viral components, or antibody responses. Polymerase chain reaction testing provides rapid and sensitive detection of viral DNA from blood, tissue samples, or environmental swabs. Antigen detection tests including direct immunofluorescence and ELISA methods identify viral proteins in tissues. Virus isolation in cell culture provides definitive confirmation though requires specialized facilities and extended incubation. Serological tests including ELISA and indirect immunofluorescence detect antibodies indicating exposure, useful for identifying recovered or chronically infected animals that may not have detectable virus. Testing is performed only at authorized laboratories meeting containment and quality standards.

Differential diagnosis for African swine fever includes other severe systemic diseases of swine producing hemorrhagic lesions or high mortality. Classical swine fever represents the most important differential, producing nearly identical clinical and pathological presentations requiring laboratory testing for differentiation. Porcine reproductive and respiratory syndrome in severe acute form can cause mortality and reproductive losses. Erysipelas produces skin discoloration and fever. Salmonellosis may cause hemorrhagic enteritis. Severe streptococcal infections cause septicemia with mortality. Porcine dermatitis and nephropathy syndrome produces skin hemorrhages. Warfarin or similar anticoagulant toxicosis causes hemorrhage. Comprehensive laboratory investigation is essential for accurate diagnosis.

Herd-level investigation following suspicion of African swine fever involves extensive sampling and epidemiological assessment coordinated by official veterinary services. All pigs on affected premises undergo clinical examination with sampling of sick, dead, and apparently healthy animals. Epidemiological investigation traces potential introduction sources and identifies contact premises requiring surveillance or restriction. Environmental sampling may assess contamination levels on premises. Wild boar surveillance in surrounding areas evaluates potential wildlife involvement. Complete documentation of findings supports regulatory response decisions and provides information for broader outbreak investigation and control efforts.

There is no effective treatment for African swine fever, and attempting treatment of infected pigs is not permitted under regulatory frameworks governing response to this reportable disease. The virus causes severe multi-systemic damage that cannot be reversed or effectively managed with available therapeutics. Experimental antiviral compounds have shown limited efficacy in research settings but none are approved or available for field use. The absence of treatment options emphasizes the critical importance of prevention through biosecurity and rapid response through depopulation when disease is detected.

Regulatory response to confirmed African swine fever involves immediate quarantine and depopulation of affected premises rather than treatment attempts. All pigs on infected premises are humanely euthanized to eliminate virus sources and prevent further transmission. Carcasses are disposed of through methods preventing environmental contamination, typically incineration or deep burial following official protocols. Premises undergo thorough cleaning and disinfection under official supervision. Restocking is permitted only after completion of cleaning procedures and adequate waiting periods with negative environmental testing.

Supportive care for individual pigs in African swine fever scenarios is not appropriate given regulatory requirements and the lack of recovery potential with virulent strains. Resources must instead be directed toward containing the outbreak, protecting unaffected populations, and supporting affected producers through the response and recovery process. Veterinary involvement focuses on confirming diagnosis, supporting regulatory response, and advising on biosecurity measures to protect other premises.

No vaccines are currently approved for commercial use against African swine fever despite intensive global research efforts. Several vaccine candidates are in advanced development stages, with some showing promise in experimental trials. Live attenuated vaccines have demonstrated protective immunity in laboratory studies but face regulatory and safety hurdles before potential deployment. Subunit and vectored vaccines generally produce incomplete protection. Even when vaccines become available, they will likely serve as additional tools within comprehensive control programs rather than standalone solutions. The complex nature of the virus and disease continues to challenge vaccine development.

Response decisions during African swine fever outbreaks are directed by official veterinary authorities following established national and international protocols. Individual producers must comply with regulatory requirements including premises quarantine, movement restrictions, depopulation orders, and cleaning mandates. Compensation programs in many jurisdictions provide financial support for culled animals, though programs vary by country and may not fully cover losses. Producer cooperation with response efforts is essential for controlling outbreaks and minimizing overall industry impacts. Understanding regulatory frameworks in advance helps producers prepare for potential response scenarios.

Producer actions during African swine fever response focus on compliance with official directives while protecting the welfare of animals during depopulation and supporting business recovery planning. Coordination with veterinary authorities ensures appropriate methods for humane euthanasia of affected populations. Documentation of inventory and losses supports compensation claims. Communication with business partners and creditors helps manage financial impacts of sudden production cessation. Mental health support may be needed given the emotional toll of depopulating entire herds. Planning for eventual restocking and return to production begins even during active response phases.

Recovery from African swine fever at the individual animal level is rare and of limited practical relevance given regulatory requirements for depopulation. Some pigs infected with lower virulence strains may survive acute disease, but survivors often develop chronic infection with persistent virus shedding posing ongoing transmission risks. Recovered pigs may serve as carriers capable of infecting susceptible animals for extended periods. The presence of survivor animals in a population complicates disease-free status determination. For these reasons, recovery of individual animals does not factor into disease management decisions.

Premises recovery following African swine fever involves structured processes before pig production can resume. Complete depopulation must be followed by thorough cleaning and disinfection of all buildings, equipment, and accessible environmental surfaces. Specific protocols address different materials and surfaces with appropriate disinfectant selection and contact times. Manure and organic material require special handling to prevent environmental contamination. Official inspection confirms adequate cleaning before restocking is permitted. Waiting periods following cleaning allow any remaining virus to inactivate, with duration depending on regional protocols and environmental conditions.

Recovery of disease-free status at regional or national levels requires sustained surveillance demonstrating absence of virus circulation. Continued monitoring of domestic pig populations through clinical observation, mortality tracking, and laboratory testing provides evidence supporting freedom claims. Wild boar surveillance addresses this important population that may maintain virus circulation independently of domestic pigs. Maintaining disease-free status requires ongoing biosecurity vigilance and surveillance investment to quickly detect any reintroduction. International recognition of disease-free status follows demonstration of sustained absence according to World Organisation for Animal Health standards.

Industry recovery following African swine fever outbreaks encompasses economic and structural dimensions beyond individual premises. Market recovery requires rebuilding consumer confidence and reestablishing trade relationships disrupted during outbreaks. Production recovery involves restocking depopulated premises and rebuilding breeding populations that may have been substantially reduced. Price stabilization follows supply recovery after initial disruption. Policy adjustments may strengthen prevention programs based on outbreak experience. The timeline for full industry recovery extends years beyond outbreak control, with impacts persisting long after the last case is resolved.

No effective vaccine is currently available for African swine fever prevention, despite being the focus of intensive global research efforts. This absence of immunological prevention means that biosecurity represents the only effective approach to protecting pig populations from this devastating disease. Research continues on multiple vaccine platforms including live attenuated, subunit, and vectored approaches, with some candidates showing promise in experimental settings. Eventual vaccine availability may provide additional prevention tools, though biosecurity will remain essential regardless of vaccine development progress.

Biosecurity measures form the foundation of African swine fever prevention and represent the primary defense against virus introduction. Perimeter security controls access to pig production areas, with physical barriers, entry protocols, and visitor restrictions preventing unauthorized access. Vehicle management requires cleaning and disinfection before entry, with dedicated farm vehicles preferred over shared transport. Personnel protocols include clothing changes, showers, and downtime between pig contacts. Equipment and supply management ensures materials entering pig areas are free from contamination. Feed biosecurity addresses potential contamination of ingredients or finished feeds.

Swill feeding prevention represents a critical biosecurity focus given the historical importance of contaminated food waste in African swine fever transmission. Many jurisdictions prohibit feeding food waste to pigs entirely, while others require specific heat treatment to inactivate potential pathogens. Enforcement of these regulations protects pig populations from exposure through this well-documented transmission route. Producer awareness of the risks associated with feeding food scraps, including seemingly innocuous materials like sandwich leftovers, helps prevent accidental introduction.

Wild boar management contributes to African swine fever prevention in regions where these animals may harbor or transmit virus. Physical exclusion of wild boar from domestic pig facilities through adequate fencing prevents direct contact transmission. Hunting and population management may reduce wild boar density in some situations. Carcass surveillance among hunter-harvested and found-dead wild boar enables early detection of virus circulation in wildlife populations. Coordination between agricultural and wildlife management authorities supports comprehensive prevention efforts addressing both domestic and wild pig populations.

Surveillance and early detection programs provide essential support for African swine fever prevention by enabling rapid response to incursions. Clinical surveillance through trained producers and veterinarians reporting suspicious disease enables investigation of potential cases. Laboratory surveillance through testing of mortality events and disease investigations confirms negative status or detects introduction. Import inspection addresses legal pathways for virus entry through animal movement and product imports. Intelligence gathering regarding global disease occurrence informs risk assessment and prevention priorities. Rapid communication systems ensure timely response when suspicion arises.

Daily management and monitoring in the context of African swine fever prevention integrates disease awareness into routine production activities. Personnel should be trained to recognize clinical signs that might indicate African swine fever, understanding the importance of immediate reporting when suspicious disease occurs. Daily health observations should specifically assess for fever, skin discoloration, hemorrhage, and unexplained mortality that could indicate serious disease. Documentation of normal health status provides baseline for comparison when problems emerge. Clear reporting pathways ensure observations reach veterinarians and management promptly.

Biosecurity program management requires ongoing attention and periodic reassessment to maintain protective measures against African swine fever introduction. Regular review of biosecurity protocols identifies gaps or lapses requiring correction. Training and retraining of personnel ensures consistent implementation of established procedures. Auditing of critical control points confirms that intended practices are actually being followed. Documentation of biosecurity activities supports verification and continuous improvement efforts. Investment in infrastructure and systems that facilitate biosecurity compliance supports long-term prevention success.

Supply chain management addresses African swine fever risks associated with feed, replacement animals, and service providers. Feed suppliers should provide assurance regarding ingredient sourcing and contamination prevention measures. Replacement animal purchases require health documentation and ideally sourcing from operations with robust biosecurity programs. Service providers including veterinarians, maintenance personnel, and delivery drivers should follow farm biosecurity protocols. Contracts and communication establishing biosecurity expectations help ensure compliance by external parties whose activities may pose introduction risks.

Emergency preparedness for potential African swine fever introduction encompasses planning, resources, and relationships needed for effective response. Understanding regulatory requirements and response protocols enables rapid compliance when direction comes from authorities. Maintaining current inventory records supports compensation processes and response planning. Relationships with veterinarians, regulatory officials, and industry organizations facilitate communication during emergencies. Business continuity planning addresses financial and operational impacts of potential outbreak response. Mental health resources and support systems prepare for the psychological demands of potential depopulation events.

Economic considerations pervade African swine fever prevention decision-making at individual farm and industry levels. Investment in biosecurity infrastructure and programs represents ongoing expense that must be balanced against production priorities. The potential costs of African swine fever introduction, including complete herd loss and extended production cessation, generally justify substantial prevention investment. Industry-level investments in surveillance, research, and preparedness distribute costs while providing collective benefit. Insurance products in some markets help manage financial risks associated with catastrophic disease events.

All domestic pig breeds demonstrate complete susceptibility to African swine fever, with no breed exhibiting resistance or reduced susceptibility to infection or disease. European, Asian, and American breeds regardless of their development history all suffer severe disease when exposed to virulent African swine fever virus strains. Heritage breeds, commercial hybrids, and specialized lines all face equivalent risk. This universal susceptibility reflects the lack of any evolutionary exposure to the virus among domestic pig ancestors, which diverged from African wild suids long before African swine fever virus evolution. Genetic selection for resistance is not feasible as a practical prevention strategy.

Wild boar and feral pig populations demonstrate susceptibility equivalent to domestic pigs, creating wildlife reservoirs that complicate control efforts in regions where virus becomes established. Wild boar populations in Europe and Asia have experienced devastating mortality from African swine fever, with virus circulation persisting in surviving populations. The interface between wild and domestic pig populations creates ongoing transmission risks requiring management attention. Feral pig populations in other regions remain susceptible if virus were introduced, potentially establishing additional wildlife reservoirs.

African wild suids including warthogs and bushpigs serve as natural reservoir hosts for African swine fever virus, carrying infection without clinical disease due to long evolutionary coexistence with the virus. This adapted tolerance does not provide any protection for domestic pigs and cannot be transferred through breeding approaches. The reservoir status of African wild suids maintains virus circulation in endemic areas and poses ongoing risks for domestic pig production in Africa. Understanding this ecological relationship informs control strategies in endemic regions while highlighting the evolutionary novelty of the virus for domestic pig populations elsewhere.

Classical swine fever represents the most important related condition to African swine fever, producing nearly identical clinical presentation and requiring laboratory differentiation. Both diseases cause hemorrhagic fever with high mortality, skin discoloration, and multi-organ pathology. Classical swine fever is also a reportable disease with similar regulatory implications. The clinical similarity means that any hemorrhagic disease syndrome in pigs requires testing to distinguish these two devastating viral diseases. Historical documentation sometimes confused the two conditions before laboratory diagnostics enabled definitive differentiation.

Other differential diagnoses for African swine fever include various conditions causing mortality, hemorrhage, or skin discoloration in pigs. Porcine reproductive and respiratory syndrome in severe presentations causes mortality and reproductive losses. Erysipelas produces fever and skin lesions that may be confused with early African swine fever. Severe salmonellosis and other septicemic bacterial infections cause systemic illness and mortality. Acute porcine dermatitis and nephropathy syndrome produces hemorrhagic skin lesions. Anticoagulant toxicosis from rodenticide exposure causes hemorrhage. Comprehensive diagnostic investigation addresses all plausible differential diagnoses.

Complications of African swine fever are of limited clinical relevance given the typically fatal outcome and regulatory requirements for depopulation. Secondary bacterial infections may complicate the clinical picture as immune dysfunction from viral infection permits opportunistic pathogen proliferation. Concurrent infections with other swine pathogens may occur coincidentally but do not significantly alter the course or outcome of African swine fever. The severity and regulatory status of African swine fever overshadow any secondary considerations, with disease management focused entirely on containment and elimination rather than clinical management of complications.